Case Report

Audiological Profiling and Rehabilitation Outcomes in a Child with Mucopolysaccharidosis Type II

Abstract

Background and Aim: Mucopolysaccharidosis (MPS II) is a group of rare lysosomal storage disorders, with seven sub-types. MPS II also known as Hunter’s syndrome is the only subtype that is affected by X-linked inheritance, while the others are of autosomal inheritance.
The Case: The study aimed to discuss the impact of Hunter syndrome, its pathophysiology, assessment diagnosis, audiological profiling, rehabilitation, and prognostic factors in a child diagnosed with MPS II at the age of 4 years. The auditory symptoms begin around at the age of 2–4 years, as the harmful molecule builds up in the middle ear bone sizes resulting in joint stiffness, and conductive hearing loss gradually progressing into mixed hearing loss with varying degree. Each audiological test finding was linked to the pathophysiology of MPS II, with the discussion emphasising suitable rehabilitative options and importance of multidisciplinary management of hunter syndrome.
Conclusion: The atypical manifestations of MPS II with fluctuating hearing loss is suggestive of the need for early identification, adequate profiling, appropriate rehabilitative measures and role of allied professionals in management of the disorder.

1. Hunter C. A Rare Disease in Two Brothers. Proc R Soc Med. 1917;10(Sect Study Dis Child):104-16. [DOI:10.1177/003591571701001833]
2. D’Avanzo F, Rigon L, Zanetti A, Tomanin R. Mucopolysaccharidosis Type II: One Hundred Years of Research, Diagnosis, and Treatment. Int J Mol Sci. 2020;21(4):1258. [DOI:10.3390/ijms21041258]
3. Malm G, Lund AM, Månsson JE, Heiberg A. Mucopolysaccharidoses in the Scandinavian countries: incidence and prevalence. Acta Paediatr. 2008;97(11):1577-81. [DOI:10.1111/j.1651-2227.2008.00965.x]
4. Gajula P, Ramalingam K, Bhadrashetty D. A rare case of mucopolysaccharidosis: Hunter syndrome. J Nat Sci Biol Med. 2012;3(1):97-100. [DOI:10.4103/0976-9668.95984]
5. Bicalho CG, de Araújo Leão EKE, de Andrade ÁM, Acosta AX. Hearing Loss in Mucopolysaccharidosis. Int Arch Otorhinolaryngol. 2021;25(3):e386-91.
[DOI:10.1055/s-0040-1712107]
6. Wolfberg J, Chintalapati K, Tomatsu S, Nagao K. Hearing Loss in Mucopolysaccharidoses: Current Knowledge and Future Directions. Diagnostics (Basel). 2020;10(8):554. [DOI:10.3390/diagnostics10080554]
7. Wraith JE, Scarpa M, Beck M, Bodamer OA, De Meirleir L, Guffon N, et al. Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy. Eur J Pediatr. 2008;167(3):267-77. [DOI:10.1007/s00431-007-0635-4]
8. Moog JS, Geers AE. Scales of Early Communication Skills for Hearing-Impaired Children. St. Louis, MO: Central Institute for the Deaf; 1975.
9. Swapna N, Prema K, Geetha Y. Swapna N, Prema KS, Geetha YV. Development of an intervention module for preschool children with communication disorders (Phase II). Mysuru: All India Institute of Speech and Hearing; 2010. Available from: http://203.129.241.86:8080/xmlui/handle/123456789/4097
10. Frankenburg WK, Dodds JB. The Denver Developmental Screening Test. J Pediatr. 1967;71(2):181-91. [DOI:10.1016/S0022-3476(67)80070-2]
11. Wechsler D, Kodama H. Wechsler intelligence scale for children. New York: Psychological corporation; 1949.
12. Harrison JE, Weber S, Jakob R, Chute CG. ICD-11: an international classification of diseases for the twenty-first century. BMC Med Inform Decis Mak. 2021;21(Suppl 6):206. [DOI:10.1186/s12911-021-01534-6]
13. Taylor M, Khan S, Stapleton M, Wang J, Chen J, Wynn R, et al. Hematopoietic Stem Cell Transplantation for Mucopolysaccharidoses: Past, Present, and Future. Biol Blood Marrow Transplant. 2019;25(7):e226-46. [DOI:10.1016/j.bbmt.2019.02.012]
14. Keilmann A, Nakarat T, Bruce IA, Molter D, Malm G; HOS Investigators. Hearing loss in patients with mucopolysaccharidosis II: data from HOS - the Hunter Outcome Survey. J Inherit Metab Dis. 2012;35(2):343-53. [DOI:10.1007/s10545-011-9378-5]
15. Guillén-Navarro E, Domingo-Jiménez MR, Alcalde-Martín C, Cancho-Candela R, Couce ML, Galán-Gómez E, et al. Clinical manifestations in female carriers of mucopolysaccharidosis type II: a Spanish cross-sectional study. Orphanet J Rare Dis. 2013;8:92.
16. Hashmi MS, Gupta V. Mucopolysaccharidosis Type II. StatPearls. Treasure Island (FL): StatPearls Publishing; 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560829/
17. Tomatsu S, Pitz S, Hampel U. Ophthalmological Findings in Mucopolysaccharidoses. J Clin Med. 2019;8(9):1467. [DOI:10.3390/jcm8091467]
18. Carney AE, Moeller MP. Treatment efficacy: hearing loss in children. J Speech Lang Hear Res. 1998;41(1):S61-84. [DOI:10.1044/jslhr.4101.s61]
19. Rao K, Carthik P, Varghese, A, Seth D, Bhat M. Audiological and Speech and Language Characteristics of a Case with Hunter’s Syndrome. Indian J Otolaryngol Head Neck Surg. 2023. [DOI:10.1007/s12070-023-04144-y]
20. Kiaer EK, Møller TR, Wetke R. [Hunter’s syndrome and hearing impairment]. Ugeskr Laeger. 2010;172(45):3115-6. Danish.
21. Muenzer J, Beck M, Eng CM, Escolar ML, Giugliani R, Guffon NH, et al. Multidisciplinary management of Hunter syndrome. Pediatrics. 2009;124(6):e1228-39.
Files
IssueVol 33 No 2 (2024) QRcode
SectionCase Report(s)
DOI https://doi.org/10.18502/avr.v33i2.14820
Keywords
Mucopolysaccharidosis II auditory tests Hunters hearing loss conductive prognosis
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Nisha KV, Teja G, Thomas NM, Thakur N, Valsa P, Sujeeth PR, Prabhu P. Audiological Profiling and Rehabilitation Outcomes in a Child with Mucopolysaccharidosis Type II. Aud Vestib Res. 2023;33(2):172-183.